These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 6843787)

  • 1. Sex-linked and other genetic factors in the development of tolerance to the anticholinesterase, DFP.
    Russell RW; Overstreet DH; Netherton RA
    Neuropharmacology; 1983 Jan; 22(1):75-81. PubMed ID: 6843787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective breeding for sensitivity to DFP: generalization of effects beyond criterion variables.
    Russell RW; Overstreet DH; Messenger M; Helps SC
    Pharmacol Biochem Behav; 1982 Nov; 17(5):885-91. PubMed ID: 6891070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective breeding for sensitivity to the anticholinesterase DFP.
    Overstreet DH; Russell RW; Helps SC; Messenger M
    Psychopharmacology (Berl); 1979 Sep; 65(1):15-20. PubMed ID: 116286
    [No Abstract]   [Full Text] [Related]  

  • 4. Selective breeding for diisopropyl fluorophosphate-sensitivity: behavioural effects of cholinergic agonists and antagonists.
    Overstreet DH; Russell RW
    Psychopharmacology (Berl); 1982; 78(2):150-5. PubMed ID: 6817373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective breeding for differences in cholinergic function: sex differences in the genetic regulation of sensitivity to the anticholinesterase, DFP.
    Overstreet DH; Russell RW
    Behav Neural Biol; 1984 Mar; 40(2):227-38. PubMed ID: 6732712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental tests of hypotheses about neurochemical mechanisms underlying behavioral tolerance to the anticholinesterase, diisopropyl fluorophosphate.
    Russell RW; Overstreet DH; Cotman CW; Carson VG; Churchill L; Dalglish FW; Vasquez BJ
    J Pharmacol Exp Ther; 1975 Jan; 192(1):73-85. PubMed ID: 164530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and disappearance of subsensitivity to pilocarpine following a single administration of the irreversible anticholinesterase angent, DFP.
    Overstreet DH; Helps SC; Prescott AM; Schiller GD
    Psychopharmacology (Berl); 1977 May; 52(3):263-9. PubMed ID: 406629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Failure of cycloheximide to alter rate of recovery of temperature following acute DFP treatment.
    Overstreet DH; Schiller GD; Day TA
    Eur J Pharmacol; 1977 Jul; 44(2):187-90. PubMed ID: 885167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sex differences following pharmacological manipulation of the cholinergic system by DFP and pilocarpine.
    Overstreet DH; Russell RW; Helps SC; Runge P; Prescott AM
    Psychopharmacology (Berl); 1979 Mar; 61(1):49-58. PubMed ID: 108719
    [No Abstract]   [Full Text] [Related]  

  • 10. Reduced behavioral effects of pilocarpine during chronic treatment with DFP.
    Overstreet DH
    Behav Biol; 1974 May; 11(1):49-58. PubMed ID: 4833225
    [No Abstract]   [Full Text] [Related]  

  • 11. Reduced hypothermic effects of cholinomimetic agents following chronic anticholinesterase treatment.
    Overstreet DH; Kozar MD; Lynch GS
    Neuropharmacology; 1973 Nov; 12(11):1017-32. PubMed ID: 4768636
    [No Abstract]   [Full Text] [Related]  

  • 12. Selective breeding for differences in cholinergic function: pre- and postsynaptic mechanisms involved in sensitivity to the anticholinesterase, DFP.
    Overstreet DH; Russell RW; Crocker AD; Schiller GD
    Brain Res; 1984 Mar; 294(2):327-32. PubMed ID: 6704730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of ovariectomy on the sex-dependent effects of the anticholinesterase diisopropyl fluorophosphate.
    Overstreet DH; Russell RW; Kerni W; Netherton RA
    Psychopharmacology (Berl); 1981; 74(4):391-2. PubMed ID: 6794089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative assessment of tolerance development to diisopropylfluorophosphate.
    Lim DK; Fernando JC; Hoskins B; Ho IK
    Pharmacol Biochem Behav; 1987 Feb; 26(2):281-6. PubMed ID: 3575352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antagonism of anticholinesterase (DFP) toxicity by donepezil plus scopolamine: a preliminary study.
    Janowsky DS; Davis JM; Overstreet DH
    Pharmacol Biochem Behav; 2004 Feb; 77(2):337-43. PubMed ID: 14751462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of muscarinic and nicotinic receptors in behavioral tolerance to DFP.
    Overstreet DH; Russell RW; Vasquez BJ; Dalglish FW
    Pharmacol Biochem Behav; 1974; 2(1):45-54. PubMed ID: 4828482
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacological analysis of diisopropyl fluorophosphate: effects on core temperature, heart rate, and motor activity in the unrestrained rat.
    Gordon CJ
    Pharmacol Biochem Behav; 1996 Oct; 55(2):185-94. PubMed ID: 8951953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autonomic and behavioral responses of selectively bred hypercholinergic rats to oxotremorine and diisopropyl fluorophosphate.
    Rezvani AH; Overstreet DH; Ejantkar A; Gordon CJ
    Pharmacol Biochem Behav; 1994 Jul; 48(3):703-7. PubMed ID: 7938125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antinociceptive effect of diisopropylphosphofluoridate: development of tolerance and lack of cross-tolerance to morphine.
    Costa LG; Murphy SD
    Neurobehav Toxicol Teratol; 1985; 7(3):251-6. PubMed ID: 2993935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of tolerance to the anticholinesterase, DFP: acetylcholine levels and dynamics in the rat brain.
    Russell RW; Carson VG; Booth RA; Jenden DJ
    Neuropharmacology; 1981 Dec; 20(12A):1197-201. PubMed ID: 7322295
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.